Volume 50, Issue 3, Pages (March 2009)

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Volume 42, Issue 6, Pages (June 2005)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Virological tools to diagnose and monitor hepatitis C virus infection
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Volume 154, Issue 4, Pages (March 2018)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
From non-A, non-B hepatitis to hepatitis C virus cure
What is the long-term outcome of the liver allograft?
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Unmet clinical need in autoimmune liver diseases
Autophagy in the liver Journal of Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
De novo autoimmune hepatitis after liver transplantation
Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg 
Volume 65, Issue 2, Pages (August 2016)
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 50, Issue 4, Pages (April 2009)
Fen Huang, Chenchen Yang, Xinying Zhou, Wenhai Yu, Qiuwei Pan 
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Volume 56, Issue 6, Pages (June 2012)
Immigration and viral hepatitis
Volume 64, Issue 6, Pages (June 2016)
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Quiz Page March 2014 American Journal of Kidney Diseases
Volume 51, Issue 2, Pages (August 2009)
Volume 62, Issue 3, Pages (March 2015)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
Quiz Page August 2013 American Journal of Kidney Diseases
Volume 44, Issue 2, Pages (February 2006)
Volume 70, Issue 5, Pages (May 2019)
Quiz Page January 2010 American Journal of Kidney Diseases
Volume 120, Issue 4, Pages (March 2001)
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 50, Issue 3, Pages 622-624 (March 2009) Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients  René Gérolami  Journal of Hepatology  Volume 50, Issue 3, Pages 622-624 (March 2009) DOI: 10.1016/j.jhep.2008.12.008 Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 1 (A) Evolution of liver biological markers (ALT, AST, and GGT) and virological markers in serum. HEV RNA remained at stable titers from March 2007 to March 2008. (B and C). Liver biopsy was performed in August 2007 showing mild mononuclear inflammation with peace-meal necrosis and periportal fibrosis (arrows) ((B) haematoxylin and eosin; (C) Reticulin staining. Original magnification 200×). UDCA, ursodeoxychloic acid. [This figure appears in colour on the web.] Journal of Hepatology 2009 50, 622-624DOI: (10.1016/j.jhep.2008.12.008) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions